Search - tctmd.com

Displaying 1 - 7 of 7

Sort: Relevancy | Date

Presentation ACC 2025

Outcomes after FFR-Guided PCI vs. CABG: Final 5-Year Follow-up of the FAME 3 Trial

Presenter: William Fearon

March 30, 2025

Presentation TCT 2022

A Randomised Controlled Trial Assessing the Value of Computed Tomography Cardiac Angiography (CTCA) in Improving Patient Satisfaction and Reducing Contrast Load, Procedural Duration, and Complications in Patients Who Had Previous Bypass Operation (CABG)…

Presenter: Daniel Jones

September 19, 2022

Presentation TCT 2022

TCT 262: Screening selection according to the SYNTAX Score 2020 in the FASTTRACK CABG, - a First In Man study - assessing the feasibility and safety of sole MSCT guidance for CABG performance

Presenter: Patrick Serruys

September 17, 2022

Presentation SIF 2019

My Most Complex Left Main Intervention

Presenter: Jasvindar Singh

March 29, 2019

Presentation SIF 2019

Mea Culpa, Mea Culpa, Mea Maxima Culpa

Presenter: David G. Rizik

March 28, 2019

Presentation TCT 2016

FFR in the setting of CABG and AS/AVR/TAVR

Presenter: Bernard De Bruyne, Allen Jeremias, Emanuele Barbato

November 01, 2016

Presentation Stanford Coronary Physiology Conference 2016

Will FFR-Directed PCI Be Better Than CABG? Update on the FAME 3 trial

Presenter: William F. Fearon

October 28, 2016

Advertisement

Outcomes after FFR-Guided PCI vs. CABG: Final 5-Year Follow-up of the FAME 3 Trial

A Randomised Controlled Trial Assessing the Value of Computed Tomography Cardiac Angiography (CTCA) in Improving Patient Satisfaction and Reducing Contrast Load, Procedural Duration, and Complications in Patients Who Had Previous Bypass Operation (CABG)…

TCT 262: Screening selection according to the SYNTAX Score 2020 in the FASTTRACK CABG, - a First In Man study - assessing the feasibility and safety of sole MSCT guidance for CABG performance

My Most Complex Left Main Intervention

Mea Culpa, Mea Culpa, Mea Maxima Culpa

FFR in the setting of CABG and AS/AVR/TAVR

Will FFR-Directed PCI Be Better Than CABG? Update on the FAME 3 trial

Advertisement

Advertisement

Sign In

Forgot Your Password?

Search TCTMD

CME TITLE

Sign up for our newsletter

Search TCTMD

Submit an Event

Become a PREMIUM MEMBER or LOG IN to view exclusive content

REGISTER for free or LOG IN to view this content